
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization
Chaochao Xu, Lina Fan, Yifeng Lin, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 179
Chaochao Xu, Lina Fan, Yifeng Lin, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 179
Showing 1-25 of 179 citing articles:
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 298
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 298
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer
Ni Wang, Jing‐Yuan Fang
Trends in Microbiology (2022) Vol. 31, Iss. 2, pp. 159-172
Closed Access | Times Cited: 181
Ni Wang, Jing‐Yuan Fang
Trends in Microbiology (2022) Vol. 31, Iss. 2, pp. 159-172
Closed Access | Times Cited: 181
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
Shanshan Jiang, Yile Xie, Xiuying Xiao, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 781-797.e9
Open Access | Times Cited: 151
Shanshan Jiang, Yile Xie, Xiuying Xiao, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 781-797.e9
Open Access | Times Cited: 151
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 121
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 121
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway
Daichi Nomoto, Yoshifumi Baba, Yang Liu, et al.
Cancer Letters (2022) Vol. 530, pp. 59-67
Open Access | Times Cited: 74
Daichi Nomoto, Yoshifumi Baba, Yang Liu, et al.
Cancer Letters (2022) Vol. 530, pp. 59-67
Open Access | Times Cited: 74
Colorectal cancer and gut microbiota studies in China
Zikai Wang, Wanyue Dan, Nana Zhang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Zikai Wang, Wanyue Dan, Nana Zhang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Intestinal bacteria and colorectal cancer: etiology and treatment
Michael W. Dougherty, Christian Jobin
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 57
Michael W. Dougherty, Christian Jobin
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 57
Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression
Yuxiao Chang, Ziran Huang, Fengyi Hou, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 49
Yuxiao Chang, Ziran Huang, Fengyi Hou, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 49
Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis
Gang Chen, Chunna Gao, Shan Jiang, et al.
Journal of Advanced Research (2023) Vol. 56, pp. 167-179
Open Access | Times Cited: 47
Gang Chen, Chunna Gao, Shan Jiang, et al.
Journal of Advanced Research (2023) Vol. 56, pp. 167-179
Open Access | Times Cited: 47
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer
Yuqing Zou, Shuling Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 539-567
Closed Access | Times Cited: 44
Yuqing Zou, Shuling Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 539-567
Closed Access | Times Cited: 44
Effects of Helicobacter pylori infection on intestinal microbiota, immunity and colorectal cancer risk
Veronika Engelsberger, Markus Gerhard, Raquel Mejías‐Luque
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 31
Veronika Engelsberger, Markus Gerhard, Raquel Mejías‐Luque
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 31
Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma
Liuyang Cai, Hengyan Zhu, Qianqian Mou, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Liuyang Cai, Hengyan Zhu, Qianqian Mou, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Chun Ye, Xiao Liu, Zilun Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 25
Chun Ye, Xiao Liu, Zilun Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 25
Tumor microenvironment as a complex milieu driving cancer progression: a mini review
Zhengrui Li, Jing Li, Xiaolei Bai, et al.
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 20
Zhengrui Li, Jing Li, Xiaolei Bai, et al.
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 20
Fusobacterium nucleatum promotes colorectal cancer liver metastasis via miR-5692a/IL-8 axis by inducing epithelial-mesenchymal transition
Yulong Yu, Han Yin, Bili Wu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 3
Yulong Yu, Han Yin, Bili Wu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 3
SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy
Peng Hui Wang, Jiannan Qiu, Yuan Fang, et al.
Cell Death and Differentiation (2025)
Open Access | Times Cited: 2
Peng Hui Wang, Jiannan Qiu, Yuan Fang, et al.
Cell Death and Differentiation (2025)
Open Access | Times Cited: 2
Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development
Tanushree Mondal, Debasish Chattopadhyay, P. Mondal, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140196-140196
Closed Access | Times Cited: 2
Tanushree Mondal, Debasish Chattopadhyay, P. Mondal, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140196-140196
Closed Access | Times Cited: 2
Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer
Hao Zhang, Yuan Tian, Chunjie Xu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Hao Zhang, Yuan Tian, Chunjie Xu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer
Xudong Zhu, Rongpu Liang, Tianyun Lan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004219-e004219
Open Access | Times Cited: 68
Xudong Zhu, Rongpu Liang, Tianyun Lan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004219-e004219
Open Access | Times Cited: 68
Carcinogenic microbiota and its role in colorectal cancer development
Tomasz M. Karpiński, Marcin Ożarowski, Mark Stasiewicz
Seminars in Cancer Biology (2022) Vol. 86, pp. 420-430
Closed Access | Times Cited: 59
Tomasz M. Karpiński, Marcin Ożarowski, Mark Stasiewicz
Seminars in Cancer Biology (2022) Vol. 86, pp. 420-430
Closed Access | Times Cited: 59
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Yan Chen, Fahong Wu, Pengqiang Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Yan Chen, Fahong Wu, Pengqiang Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis
Xiaoxue Lu, Qiaolin Xu, Yanan Tong, et al.
Cell Reports (2022) Vol. 40, Iss. 3, pp. 111127-111127
Open Access | Times Cited: 43
Xiaoxue Lu, Qiaolin Xu, Yanan Tong, et al.
Cell Reports (2022) Vol. 40, Iss. 3, pp. 111127-111127
Open Access | Times Cited: 43
Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
Suwen Ou, Hufei Wang, Yangbao Tao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 43
Suwen Ou, Hufei Wang, Yangbao Tao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 43
Mechanism and strategies of immunotherapy resistance in colorectal cancer
Jiqi Shan, Dong Han, Chunyi Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Jiqi Shan, Dong Han, Chunyi Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41